Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21124
Title: Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host.
Austin Authors: Trubiano, Jason A ;Slavin, Monica A;Thursky, Karin A;Grayson, M Lindsay ;Phillips, Elizabeth J
Affiliation: Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia
National Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Parkville, Victoria, Australia
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia
Department of Infectious Diseases, Vanderbilt University Medical Centre, Nashville, Tenn, USA
Issue Date: Sep-2019
metadata.dc.date: 2019-06-13
Publication information: The Journal of Allergy and Clinical Immunology. In Practice 2019; 7(7): 2151-2153
Abstract: Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21124
DOI: 10.1016/j.jaip.2019.05.051
ORCID: 0000-0002-5111-6367
PubMed URL: 31253580
Type: Journal Article
Subjects: Antibiotic allergy
Antibiotic allergy testing
Penicillin allergy
Penicillin allergy testing
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.